TKPHF - Takeda Pharmaceutical Co Ltd (TAK) CEO Christophe Weber on Q1 2021 Results - Earnings Call Transcript
Takeda Pharmaceutical Co Ltd (TAK)
Q1 2021 Earnings Conference Call
July 31, 2020, 05:30 ET
Company Participants
Takashi Okubo - Global Head, IR, Global Finance
Christophe Weber - President, CEO & Representative Director
Andrew Plump - President, Research & Development & Director
Constantine Saroukos - CFO & Director
Masato Iwasaki - President, Japan Pharma Business Unit & Director
Julie Kim - President, Plasma-Derived Therapies Business Unit
Conference Call Participants
Hidemaru Yamaguchi - Citigroup
Kazuaki Hashiguchi - Daiwa Securities
Fumiyoshi Sakai - Crédit Suisse
Seiji Wakao - Mitsubishi UFJ Morgan Stanley Securities
Presentation
Operator
Good day,